Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-04-30
1995-10-24
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514912, A61K 3155
Patent
active
054610524
ABSTRACT:
A composition for the inhibition of the abnormal postnatal axial growth of the eye of a maturing animal which comprises a pharmaceutically effective amount of a tricyclic compound, said tricyclic compound present in a carrier or diluent suitable for ocular administration. Suitable tricyclics are tertiary amines, secondary amines, and other active metabolites of tricyclic compounds.
REFERENCES:
patent: 4865599 (1989-09-01), Chiou
patent: 5055302 (1991-10-01), Laties et al.
patent: 5122522 (1992-06-01), Laties et al.
patent: 5284843 (1994-02-01), Stone et al.
The Merck Index Eleventh Edition 1989, pp. 80 and 780.
European Journal of Pharmacology, 190 (1990) 1-9. Ikeda et al.
Hoffmeister, F. and Stille, G. Psychotropic Agents, Part 1: Antipsychotics and Antidepressants, Zeelen, F. J., Chapter 16, "Chemistry Structure and Activity", (1980).
Springer-Verlag, New York, 1980.
Laties Alan M.
Stone Richard A.
Fay Zohreh
The Trustees of the University of Pennsylvania
LandOfFree
Prevention of myopia by tricyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of myopia by tricyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of myopia by tricyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1886807